Planet Labs PBC (PL) concluded trading on Tuesday at a closing price of $4.14, with 2.37 million shares of worth about $9.81 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 120.43% during that period and on December 24, 2024 the price saw a gain of about 2.99%. Currently the company’s common shares owned by public are about 275.27M shares, out of which, 198.30M shares are available for trading.
Stock saw a price change of -2.38% in past 5 days and over the past one month there was a price change of 16.81%. Year-to-date (YTD), PL shares are showing a performance of 65.99% which increased to 74.47% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.67 but also hit the highest price of $4.99 during that period. The average intraday trading volume for Planet Labs PBC shares is 3.71 million. The stock is currently trading 2.27% above its 20-day simple moving average (SMA20), while that difference is up 29.85% for SMA50 and it goes to 74.29% higher than SMA200.
Planet Labs PBC (NYSE: PL) currently have 275.27M outstanding shares and institutions hold larger chunk of about 28.62% of that.
The stock has a current market capitalization of $1.27B and its 3Y-monthly beta is at 1.33. It has posted earnings per share of -$0.41 in the same period. It has Quick Ratio of 2.32 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PL, volatility over the week remained 8.88% while standing at 9.49% over the month.
Stock’s fiscal year EPS is expected to rise by 34.21% while it is estimated to increase by 53.39% in next year. EPS is likely to shrink at an annualized rate of 25.00% for next 5-years, compared to annual growth of 35.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on September 06, 2024 offering a Buy rating for the stock and assigned a target price range of between $7 and $5 to it. On May 02, 2023, JMP Securities Initiated their recommendations, while on April 18, 2023, Citigroup Initiated their ratings for the stock with a price target of $6. Stock get an Equal-weight rating from Morgan Stanley on January 23, 2023.
